124 Results for "

IL18

" in MedChemExpress (MCE) Product Catalog:
Products (124)

124 Results for "IL18" in MCE Product Catalog:

Cat. No.: HY-P78316
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: IL18RAP; IL-1RAcPL; Interleukin 18 Receptor Accessory Protein; CDw218b; AcPL; IL-1R-7; CD218b; IL-1R7; Interleukin-18 Receptor Accessory Protein; Interleukin-18 Receptor Accessory Protein-Like; CD218 Antigen-Like FamILy Member B; Cluster Of Differentiatio
Species:  
Mouse
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P72573
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IL18RAP; IL-1RAcPL; Interleukin 18 Receptor Accessory Protein; CDw218b; AcPL; IL-1R-7; CD218b; IL-1R7; Interleukin-18 Receptor Accessory Protein; Interleukin-18 Receptor Accessory Protein-Like; CD218 Antigen-Like FamILy Member B; Cluster Of Differentiatio
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P76425
Purity:  ≥ 95%, as determined by reducing SDS-PAGE or Bis-Tris PAGE.
Synonyms: IL18RAP; IL-1RAcPL; Interleukin 18 Receptor Accessory Protein; CDw218b; AcPL; IL-1R-7; CD218b; IL-1R7; Interleukin-18 Receptor Accessory Protein; Interleukin-18 Receptor Accessory Protein-Like; CD218 Antigen-Like FamILy Member B; Cluster Of Differentiatio
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P705145
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: IL18RAP; IL-1RAcPL; Interleukin 18 Receptor Accessory Protein; CDw218b; AcPL; IL-1R-7; CD218b; IL-1R7; Interleukin-18 Receptor Accessory Protein; Interleukin-18 Receptor Accessory Protein-Like; CD218 Antigen-Like FamILy Member B; Cluster Of Differentiatio
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P10939A
Target:  

Caspase Pyroptosis

Research Areas:  

Inflammation/Immunology Cancer

Ac-DMLD-CMK TFA is a caspase 3 inhibitor and a GSDME inhibitor. Ac-DMLD-CMK TFA binds directly to the catalytic domain of caspase-3, blocks caspase-3-mediated cleavage of GSDME, inhibits the activation of caspase 3 and Gsdme in the caspase 3-Gsdme signaling pathway, and reduces the levels of pyroptosis and apoptosis as well as the expression of LDH, IL-6, IL-1β and IL-18. Ac-DMLD-CMK TFA alleviates renal function deterioration, renal tubular epithelial cell injury, inflammatory cytokine secretion, pulmonary structural damage, and chemotherapy-induced nephrotoxicity .
loading...
    loading...
Cat. No.: HY-P992238

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

Anti-IL-18RAP Antibody is a monoclonal antibody targeting IL-18RAP/IL-18RB. It can be used in ELISA, FACS, and functional assays. For isotype controls of Anti-IL-18RAP Antibody, please refer to Human IgG1 kappa, Isotype Control (HY-P99001).
loading...
    loading...
Cat. No.: HY-P992239

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

Anti-IL-18Rα Antibody is a monoclonal antibody targeting IL-18Ra. It can be used in ELISA, FACS, and functional assays. For isotype controls of Anti-IL-18Rα Antibody, please refer to Human IgG1 kappa, Isotype Control (HY-P99001).
loading...
    loading...
Cat. No.: HY-P992046

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

Anti-IL-18 Antibody is an anti-IL-18 antibody. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001).
loading...
    loading...
Cat. No.: HY-178053
CAS No.: 1191937-43-5
AHR agonist 10 is a potent AHR agonist (EC50 = 2.01 nM). AHR agonist 10 can elevate the transcript levels of key AHR downstream pathway target genes, including CYP1A1 and CYP1B1. AHR agonist 10 can downregulate the expression levels of CD36, IL-18 and shows low cytotoxicity (>40 μM) to normal cells. AHR agonist 10 can suppress the expression of CCL5, CCL20, IL-6, IL-8, S100A9, TLR4, TNF-α, and TNFR1, demonstrating that AHR agonist 10 effectively modulate inflammatory responses through AHR dependent signaling pathways. AHR agonist 10 can be used for psoriasis research .
loading...
    loading...
Cat. No.: HY-185311
CAS No.: 3119435-52-5
NEK7 degrader-3 is an orally active and brain-penetrant NEK7 molecular glue degrader with a DC50 of 33.1 nM. NEK7 degrader-3 mediates interaction between NEK7 and E3 ligase cereblon, promoting proteasomal degradation of NEK7 and attenuating NLRP3 inflammasome-mediated inflammatory responses. NEK7 degrader-3 inhibits caspase-1 activity, cytokine release of IL-1β, IL-1α, and IL-18, and pyroptosis-related plasma membrane permeabilization. NEK7 degrader-3 shows antiinflammatory activity in an LPS (HY-D1056)-induced neuroinflammation mouse model. NEK7 degrader-3 can be used for the research of neuroinflammation .
loading...
    loading...
Cat. No.: HY-NP192
Sericin is an orally active globular protein produced by silkworm cocoons. Sericin inhibits the expression of COX2, iNOS, TLR4, MAPK and NF-κB; reduces the levels of IL-18, IL-1 and CCL2; antagonizes the activity of AChE; and downregulates the expression of Bcl-2. Sericin enhances the PI3K/AKT-mediated insulin signaling pathway. Sericin inhibits the activity of tyrosinase (Tyrosinase), scavenges ROS, chelates metal ions, and increases the levels of antioxidant enzymes. Sericin induces apoptosis and arrests the cell cycle. Sericin exhibits antibacterial, moisturizing, cardioprotective and anticoagulant properties. Sericin can be used in research related to type 2 diabetes, hyperlipidemia, obesity, Alzheimer's disease, colon cancer, peripheral nerve injury and ischemic myocardial infarction .
loading...
    loading...
Cat. No.: HY-113298R
CAS No.: 498-23-7
Synonyms: Methylmaleic acid (Standard); Citraconate (Standard)
Citraconic acid (Methylmaleic acid) (Standard) is the analytical standard of Citraconic acid (HY-113298). This product is intended for research and analytical applications. Citraconic acid is an orally active inhibitor targeting the NLRP3 inflammasome and Keap1-Nrf2 pathway. Citraconic acid reduces reactive oxygen species (ROS) generation by inhibiting succinate dehydrogenase (SDH) activity. Citraconic acid also modifies the conformation of Keap1 protein, relieves its inhibition of Nrf2, promotes antioxidant gene expression, and inhibits NLRP3 activation and the release of pro-inflammatory factors such as IL-1β and IL-18. Citraconic acid has anti-inflammatory and antioxidant activities, can reduce oxidative stress and cell pyroptosis, improve tissue damage, and can be used for the research of inflammation-related diseases such as acute renal ischemia-reperfusion injury. Citraconic acid is an isomer of Itaconic acid (HY-Y052) .
loading...
    loading...
Cat. No.: HY-189235
CAS No.: 3078735-55-1
Target:  

5-HT Receptor

Research Areas:  

Cancer

IHCH-8110 is a peripherally restricted, non-brain-penetrant 5-HT2AR and 5-HT2CR agonist (Ki=47.86 nM) that antagonizes 5-HT2BR. IHCH-8110 induces CXCL10 and IL-18 expression by activating 5-HT2AR on enteric glial cells, thereby promoting CD8 + T cell recruitment and effector polarization, and avoids the risk of cardiac valvulopathy associated with 5-HT2BR activation. IHCH-8110 exhibits a low risk of hERG channel inhibition (IC50=5.96 μM) and is well tolerated, sensitizing immunologically cold colorectal cancer to PD-1 blockade therapy, making it suitable for research related to colorectal cancer .
loading...
    loading...
Cat. No.: HY-130413
CAS No.: 660430-03-5
Synonyms: Neuroprotectin D1; NPD1
Protectin D1, a neuroprotectin D1 produced by neuronal cells, is a member of a newly discovered family of bioactive products derived from docosahexaenoic acid. Protectin D1 also serves as a specialized pro-resolving mediator, exhibiting effective in vivo pro-resolving activity in various human disease models. Additionally, Protectin D1 is an inhibitor of NALP3 inflammasomes and regulates the PI3K/AKT and HIF-1α signaling pathways. Protectin D1 exerts anti-inflammatory effects by reducing ROS levels, inhibiting the expression of NALP3, ASC, and Caspase-1, and consequently decreasing the release of pro-inflammatory cytokines IL-1β and IL-18. Furthermore, Protectin D1 enhances miRNA-210 expression, activates the PI3K/AKT signaling pathway, and exerts cardioprotective effects. Protectin D1 holds promise for research in cardiovascular diseases and inflammatory disorders .
loading...
    loading...
Cat. No.: HY-P11935
CAS No.: 2410535-57-6
RR-171 is an amino acid polypeptide and an inhibitor of the Wnt signaling pathway. RR-171 reduces the expression levels of Wnt-1, GSK3β and β-catenin. RR-171 induces apoptosis (Apoptosis) in pancreatic cancer cells, which is characterized by an increased Bax/Bcl-2 ratio, activation of Caspase-3/7/9, and increased Cleaved-PARP; this pro-apoptotic effect can be partially reversed by Z-VAD-FMK (HY-16658B). RR-171 also induces pyroptosis (Pyroptosis) in pancreatic cancer cells, which is manifested by activation of the NLRP-3 inflammasome, activation of Caspase-1, cleavage of GSDMD, upregulation of IL-1β and IL-18, and increased LDH release; this pro-pyroptotic effect can be partially reversed by VX-765 (HY-13205). RR-171 inhibits the viability, proliferation and colony formation of pancreatic cancer cells, with low cytotoxicity against normal cells. RR-171 downregulates the expression of Ki-67 and PCNA in tumor tissues in vivo, with favorable biosafety. RR-171 can be used in studies related to pancreatic cancer .
loading...
    loading...
Cat. No.: HY-160793
CAS No.: 501950-47-6
Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

NSC80734 is a IL- 18 inhibitor. NSC80734 disrupts hIL-18 binding to the ectromelia virus IL-18BP. NSC80734 inhibits IL-18-induced production of IFN-γ .
loading...
    loading...
Cat. No.: HY-P704113
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: Interleukin-18 receptor 1; IL-18R1; CDw218a; IL1RRP; IL-18R-alpha; CD218a
Species:  
Virus
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-175640
Troponin-IN-1 is a troponin inhibitor. Troponin-IN-1 protects OGD/R-injured H9c2 cardiomyocytes by reducing LDH leakage, pyroptosis and ROS accumulation. Troponin-IN-1 inhibits NO production and IL-1β/TNF-α/IL-18 release in LPS (HY-D1056)-induced RAW264.7 cells. Troponin-IN-1 acts via caspase-1/GSDMD/IL-18 pathway. Troponin-IN-1 reduces myocardial infarct size in LAD-induced myocardial ischemia/reperfusion (MI/R) male rats. Troponin-IN-1 can be used for the study of myocardial ischemia/reperfusion (MI/R) injury .
loading...
    loading...
Cat. No.: HY-111662
CAS No.: 960119-75-9
Research Areas:  

Inflammation/Immunology

Fc 11a-2, a benzimidazole compound, is an orally active and potent NLRP3 inflammasome inhibitor. Fc 11a-2 restrains the formation of NLRP3 inflammasome by inhibiting activation of caspase-1 and thus the activation of IL-1b/IL-18. Fc 11a-2 prevents the development of Dextran sulfate sodium (DSS; HY-116282C)-induced murine experimental colitis .
loading...
    loading...
Cat. No.: HY-173234
CAS No.: 1008710-58-4
Research Areas:  

Cardiovascular Disease

GI-Y2 is an orally active, selective Gasdermin D (GSDMD) inhibitor (Kd = 36.0 μM) with anti-pyroptosis activity. GI-Y2 targets GSDMD, impairs membrane anchoring of GSDMD-NT, and blocks GSDMD‑dependent lipid binding and pore formation. GI-Y2 suppresses GSDMD‑dependent pyroptosis and inflammation, mitigates atherosclerosis and cardiac injury, boosts cell survival, and reduces IL‑1β/IL‑18 secretion. GI-Y2 can be used for the research of atherosclerosis and septic myocardial injury .
loading...
    loading...